Ya Wu

Dr. Ya Wu


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Phytomedicine
Verified
Journal Article
Closed access
DWDan Wang
Dan Wang
MSMinghui Sun
Minghui Sun
YZYing Zhang
Ying Zhang
ZCZehong Chen
Zehong Chen
SZShuya Zang
Shuya Zang
YWYa Wu
Ya Wu

15 July 2025 in Nutrition, Metabolism and Cardiovascular Diseases
Verified
Journal Article
Closed access
TKTao Kou
Tao Kou
XQXin Qian
Xin Qian
YLYuhui Liu
Yuhui Liu
JLJinping Liu
Jinping Liu
DZDaifang Zhang
Daifang Zhang
YWYa Wu
Ya Wu

21 September 2023 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
ZHZhoukun He
Zhoukun He
NWNa Wang
Na Wang
LMLinpeng Mu
Linpeng Mu
ZWZhuo Wang
Zhuo Wang
JSJie Su
Jie Su
JMJiayan Mao
Jiayan Mao
Porous polydimethylsiloxane (PDMS) films with special surface wettability have potential applications in the biomedical, environmental, and structural mechanical fields. However, preparing porous PDMS films with a regular surface pattern using conventional methods, such as chemical foaming or physical pore formation, is challenging. In this study, porous PDMS films with a regular surface pattern are designed and prepared using 3D printing to ensure the formation of controllable and regular physical structures. First, the effect of the surface wettability of glass substrates with different surface energies (commercial hydrophilic glass and hydrophobic glass (F-glass) obtained by treating regular glass with 1H,1H,2H,2H-perfluorooctyl-trichlorosilane) on the structural characteristics of the 3D printed PDMS filaments is investigated systematically. Additionally, the effect of the printing speed and the surface wettability of the glass substrate on the PDMS filament morphology is investigated synchronously. Next, using the F-glass substrate and an optimized printing speed, the effects of the number of printed layers on both the morphologies of the individual PDMS filaments and porous PDMS films, and the surface wettability of the films are studied. This study reveals that regularly patterned porous PDMS films with distinct structural designs but the same controllable surface wettability, such as anisotropic surface wettability and superhydrophobicity, can be easily fabricated through 3D printing. This study provides a new method for fabricating porous PDMS films with a specific surface wettability, which can potentially expand the application of porous PDMS films.

28 August 2025 in Materials Today Bio
Verified
Journal Article
Open access
LXLingling Xu
Lingling Xu
DZDaifang Zhang
Daifang Zhang
LSLi Song
Li Song
YWYifei Wu
Yifei Wu
LJLongqi Jiang
Longqi Jiang
YWYa Wu
Ya Wu
Atherosclerosis (AS) is a chronic inflammatory disease driven by endothelial dysfunction, vascular smooth muscle cell proliferation, and insufficient resolution of inflammation. Nitric oxide (NO) plays a crucial role in vascular homeostasis by promoting endothelial cell proliferation, maintaining endothelial integrity, suppressing smooth muscle cell hyperplasia, and exerting potent anti-inflammatory effects. However, clinical application of NO is hindered by its short half-life, lack of targeting, and uncontrolled release. Here, we developed the biomimetic nanoparticles (B-NPs@MM) for targeted and controllable NO delivery by encapsulating the ultrasound (US)-responsive NO donor BNN6 into poly(lactic-co-glycolic acid) (PLGA) nanospheres followed by coating with macrophage-derived membranes. These biomimetic particles mimic natural macrophages to actively target inflamed atherosclerotic plaques and evade immune clearance. Upon localized US exposure, the system triggers rapid and on-demand NO release at the lesion site with spatiotemporal precision. In vitro and in vivo evaluations demonstrate effective NO delivery, enhanced endothelial repair, reduced inflammation, and inhibition of neointimal hyperplasia. This work presents a smart, remotely controlled NO nanotherapy platform based on artificial immune cell design, offering a promising strategy for precision treatment of AS.

15 August 2024 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
DZDaifang Zhang
Daifang Zhang
LJLongqi Jiang
Longqi Jiang
FYFengxu Yu
Fengxu Yu
PYPijun Yan
Pijun Yan
YLYong Liu
Yong Liu
XYXi Yang
Xi Yang
Introduction: Inflammatory bowel disease (IBD), as a chronic and recurrent inflammatory bowel diseases with limited therapeutic outcomes, is characterized by immune disorders and intestinal barrier dysfunction. Currently, the most medications used to cure IBD in clinic just temporarily induce and maintain remission with poor response rates and limited outcomes. Therefore, it is urgently necessary to develop an appropriate therapeutic candidate with preferable efficacy and less adverse reaction for curing IBD.Methods: Five groups of mice were utilized: control that received saline, DSS group (mice received 2.5% DSS or 4% DSS), KPV group (mice received KPV), FK506 group (mice received FK506) and NPs groups (mice received NPs). The effect of NP on the inflammatory factors of macrophage was evaluated using CCK-8, quantitative polymerase chain reaction (PCR), Elisa and Western blot (WB). Immunofluorescent staining revealed the targeting relationship between NP and Petp-1. Immunohistochemistry staining showed the effect of NP on tight junction proteins. Moreover, in vivo animal experiments confirmed that NPs reduced inflammatory levels in IBD.Results and Discussion: After administering with NPs, mice with DSS-induced acute or chronic colitis exhibited significant improvement in body weight, colon length, and disease activity index, decreased the level of the factors associated with oxidative stress (MPO, NO and ROS) and the inflammatory cytokines (TNF-α, IL-1β and IL-6), which implied that NPs could ameliorate murine colitis effectively. Furthermore, treating by NPs revealed a notable reduction of the expressions of CD68 and CD3, restoring the expression levels of tight junction proteins (Claudin-5, Occludin-1, and ZO-1) were significantly restored, surpassing those observed in the KPV and FK506 groups. which indicated that NPs can reduce inflammation and enhance epithelial barrier integrity by decreasing the infiltration of macrophages and T-lymphocytes. Collectively, those results demonstrated the effectively therapeutic outcome after using NPs in both acute and chronic colitis, suggesting that the newly co-assembled of NPs can be as a potential therapeutic candidate for colitis.

23 January 2025 in Progress in Biophysics and Molecular Biology
Verified
Journal Article
Open access
JLJiqiang Li
Jiqiang Li
WWWeiming Wang
Weiming Wang
ZLZipeng Lin
Zipeng Lin
ZLZhenyu Liu
Zhenyu Liu
RZRuilin Zhang
Ruilin Zhang
YLYong Liu
Yong Liu
Vinculin, a crucial adhesion plaque protein, plays a significant role in cell morphology and tissue development. Dysregulation of focal adhesion proteins has been linked to numerous diseases, including cardiovascular conditions, gastrointestinal disorders, and cancer. Recent studies increasingly highlight vinculin's involvement in the progression of these diseases; however, a comprehensive review remains lacking. Therefore, an in-depth and timely review is essential to consolidate the latest findings on vinculin's role in disease mechanisms. This study aims to examine how vinculin coordinates a complex network of signaling pathways across various pathological contexts.